Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21681 | 409 | 35.2 | 61% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
21681 | 1 | NEPHROLOGY CLINICAL PRACTICE GUIDELINES//SERUM MEDIATORS//BILATERAL URETER LIGATED RATS | 409 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEPHROLOGY CLINICAL PRACTICE GUIDELINES | authKW | 223973 | 1% | 100% | 3 |
2 | SERUM MEDIATORS | authKW | 167978 | 1% | 75% | 3 |
3 | BILATERAL URETER LIGATED RATS | authKW | 149315 | 0% | 100% | 2 |
4 | NEPHROLOGY PRECEPTOR | authKW | 149315 | 0% | 100% | 2 |
5 | NONRENAL DRUG CLEARANCE | authKW | 149315 | 0% | 100% | 2 |
6 | RENAL DOSE ADJUSTMENT | authKW | 149315 | 0% | 100% | 2 |
7 | DOSAGE ADJUSTMENT | authKW | 140847 | 2% | 19% | 10 |
8 | KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE | authKW | 111984 | 1% | 50% | 3 |
9 | RECH HOP MAISONNEUVE ROSEMONT | address | 99542 | 0% | 67% | 2 |
10 | RENAL IMPAIRMENT | authKW | 94658 | 7% | 5% | 28 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 3579 | 54% | 0% | 222 |
2 | Urology & Nephrology | 2302 | 22% | 0% | 91 |
3 | Medical Informatics | 210 | 3% | 0% | 12 |
4 | Health Care Sciences & Services | 160 | 5% | 0% | 19 |
5 | Medicine, General & Internal | 130 | 10% | 0% | 40 |
6 | Primary Health Care | 52 | 1% | 0% | 5 |
7 | Information Science & Library Science | 49 | 2% | 0% | 8 |
8 | Transplantation | 40 | 2% | 0% | 10 |
9 | Geriatrics & Gerontology | 29 | 2% | 0% | 7 |
10 | Computer Science, Information Systems | 20 | 2% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RECH HOP MAISONNEUVE ROSEMONT | 99542 | 0% | 67% | 2 |
2 | AGEING CLIN INTERNAL MED 2 | 74658 | 0% | 100% | 1 |
3 | BRITISH MED ASSOCCPPR | 74658 | 0% | 100% | 1 |
4 | CENTRE SANTE SERV SOCIAUX LAVAL | 74658 | 0% | 100% | 1 |
5 | CHRON DIS GRPMED FDN | 74658 | 0% | 100% | 1 |
6 | CLIN PHARMACEUT SCI PHARM | 74658 | 0% | 100% | 1 |
7 | DPE1 | 74658 | 0% | 100% | 1 |
8 | GJOVIK HOSP PHARM | 74658 | 0% | 100% | 1 |
9 | HEALTHCARE DEV PUBL HEALTHCARE ADM | 74658 | 0% | 100% | 1 |
10 | HOSP BICHAT HP | 74658 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ADVANCES IN CHRONIC KIDNEY DISEASE | 5649 | 2% | 1% | 7 |
2 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2866 | 4% | 0% | 15 |
3 | ANNALS OF PHARMACOTHERAPY | 2705 | 3% | 0% | 14 |
4 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2233 | 1% | 1% | 5 |
5 | JOURNAL OF CLINICAL PHARMACOLOGY | 1964 | 3% | 0% | 12 |
6 | AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY | 1655 | 0% | 1% | 2 |
7 | AMERICAN JOURNAL OF KIDNEY DISEASES | 1474 | 3% | 0% | 13 |
8 | SEMINARS IN DIALYSIS | 1466 | 1% | 0% | 6 |
9 | JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION | 1453 | 2% | 0% | 8 |
10 | BMC NEPHROLOGY | 1446 | 1% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LALANDE, L , CHARPIAT, B , LEBOUCHER, G , TOD, M , (2014) CONSEQUENCES OF RENAL FAILURE ON NON-RENAL CLEARANCE OF DRUGS.CLINICAL PHARMACOKINETICS. VOL. 53. ISSUE 6. P. 521 -532 | 50 | 57% | 12 |
2 | DREISBACH, AW , LERTORA, JJL , (2008) THE EFFECT OF CHRONIC RENAL FAILURE ON DRUG METABOLISM AND TRANSPORT.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 4. ISSUE 8. P. 1065-1074 | 39 | 62% | 78 |
3 | YEUNG, CK , SHEN, DD , THUMMEL, KE , HIMMELFARB, J , (2014) EFFECTS OF CHRONIC KIDNEY DISEASE AND UREMIA ON HEPATIC DRUG METABOLISM AND TRANSPORT.KIDNEY INTERNATIONAL. VOL. 85. ISSUE 3. P. 522-528 | 29 | 59% | 31 |
4 | RYAN, JC , DUNN, KW , DECKER, BS , (2014) EFFECTS OF CHRONIC KIDNEY DISEASE ON LIVER TRANSPORT: QUANTITATIVE INTRAVITAL MICROSCOPY OF FLUORESCEIN TRANSPORT IN THE RAT LIVER.AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. VOL. 307. ISSUE 12. P. R1488 -R1492 | 21 | 81% | 1 |
5 | NAUD, J , NOLIN, TD , LEBLOND, FA , PICHETTE, V , (2012) CURRENT UNDERSTANDING OF DRUG DISPOSITION IN KIDNEY DISEASE.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 52. ISSUE . P. 10S-22S | 38 | 43% | 21 |
6 | DREISBACH, AW , (2009) THE INFLUENCE OF CHRONIC RENAL FAILURE ON DRUG METABOLISM AND TRANSPORT.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 86. ISSUE 5. P. 553 -556 | 20 | 83% | 39 |
7 | KIM, GJ , JE, NK , KIM, DS , LEE, S , (2016) ADHERENCE WITH RENAL DOSING RECOMMENDATIONS IN OUTPATIENTS UNDERGOING HAEMODIALYSIS.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 41. ISSUE 1. P. 26 -33 | 15 | 94% | 0 |
8 | NAUD, J , DUMAYNE, C , NOLIN, TD , LEBLOND, FA , PICHETTE, V , (2015) DRUG PHARMACOKINETICS IN RENAL FAILURE: WHAT'S NEW?.NEPHROLOGIE & THERAPEUTIQUE. VOL. 11. ISSUE 3. P. 144 -151 | 23 | 62% | 0 |
9 | NOLIN, TD , (2015) A SYNOPSIS OF CLINICAL PHARMACOKINETIC ALTERATIONS IN ADVANCED CKD.SEMINARS IN DIALYSIS. VOL. 28. ISSUE 4. P. 325 -329 | 23 | 50% | 1 |
10 | THOMSON, BKA , NOLIN, TD , VELENOSI, TJ , FEERE, DA , KNAUER, MJ , ASHER, LJ , HOUSE, AA , URQUHART, BL , (2015) EFFECT OF CKD AND DIALYSIS MODALITY ON EXPOSURE TO DRUGS CLEARED BY NONRENAL MECHANISMS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 65. ISSUE 4. P. 574 -582 | 20 | 53% | 6 |
Classes with closest relation at Level 1 |